
-
PSG win 13th French title ahead of Aston Villa Champions League clash
-
Nick Rockett storms to victory in the 'Mullins' Grand National
-
Despair and sadness follow death of Malian musical great Amadou
-
Arsenal held by Everton, Wolves push Ipswich closer to relegation
-
Lions contender Prendergast fires Leinster to Champions Cup quarters
-
Nick Rockett wins the 'Mullins' Grand National for father and son
-
Last-gasp Buendia goal keeps Leverkusen's Bundesliga title hopes alive
-
Video shows last minutes before Gaza aid workers' deaths, Red Crescent says
-
Zverev 'mentally' affected by Australian Open defeat
-
Rahul guides Delhi to third straight IPL victory
-
Arsenal draw at Everton to edge Liverpool closer to Premier League title
-
Senate Republicans move forward with Trump tax cuts
-
Sinner regrets 'unfair' doping ban as he prepares return to courts
-
Isa hat-trick powers Toulon into Champions Cup quarters in Saracens thriller
-
'Hang tough, it won't be easy': Trump defiant on tariffs
-
Zelensky slams 'weak' US reply to Russian strike on his hometown
-
Musiala hamstring tear compounds Bayern's injury crisis
-
Selfies, goals and cheers at South Africa's grannies World Cup
-
Tsunoda frustrated with 15th in Red Bull qualifying debut
-
Rain forecast adds new element to combustible Japanese GP
-
Ukraine mourns 18 killed in Russian missile strike
-
Germany's Mueller to leave Bayern Munich after 25 years
-
India's Modi clinches defence, energy deals in Sri Lanka
-
Verstappen snatches 'special' pole for Japan GP with lap record
-
Cambodia hails opening of naval base renovated by China
-
Verstappen snatches 'insane' pole for Japan GP in track record
-
Thousands rally for South Korea's impeached ex-president Yoon
-
New Zealand hammer Pakistan by 43 runs to sweep ODI series 3-0
-
Myanmar quake death toll passes 3,300: state media
-
India's Modi in Sri Lanka for defence and energy deals
-
'No one to return to': Afghans fear Pakistan deportation
-
Fractious Republicans seek unity over Trump tax cuts
-
America's passion for tariffs rarely pays off, economists warn
-
Trump's global tariff takes effect in dramatic US trade shift
-
North Korea's Kim fires new sniper rifle while visiting troops
-
Norris fastest in McLaren 1-2 as fires again disrupt Japan GP practice
-
Vital European defence startups still facing hurdles
-
'I don't have a voice in my head': Life with no inner monologue
-
Pakistan chasing 265 to win shortened third New Zealand ODI
-
US soybeans, energy: Who is hit by China's tariff retaliation?
-
Green, Sengun lift Rockets over Thunder, Celtics clinch record
-
Ariya downs defending champ Korda to advance at LPGA Match Play
-
Ovechkin ties Gretzky's all-time record of 894 NHL goals
-
Under-pressure Doohan vows to learn from Japanese GP smash
-
Harman goes four clear at Texas Open
-
McLaughlin-Levrone, Thomas cruise to wins at opening Grand Slam Track
-
Russian strike kills 18 in Ukrainian president's home city
-
US cardinal defrocked for sex abuse dies at 94
-
Lula admits 'still a lot to do' for Indigenous Brazilians
-
England, Germany and Spain on mark in women's Nations League
SCS | -0.56% | 10.68 | $ | |
BCC | 0.85% | 95.44 | $ | |
NGG | -5.25% | 65.93 | $ | |
GSK | -6.79% | 36.53 | $ | |
AZN | -7.98% | 68.46 | $ | |
CMSD | 0.7% | 22.83 | $ | |
BCE | 0.22% | 22.71 | $ | |
BTI | -5.17% | 39.86 | $ | |
RBGPF | 100% | 69.02 | $ | |
RIO | -6.88% | 54.67 | $ | |
CMSC | 0.13% | 22.29 | $ | |
JRI | -7.19% | 11.96 | $ | |
RELX | -6.81% | 48.16 | $ | |
VOD | -10.24% | 8.5 | $ | |
RYCEF | -18.79% | 8.25 | $ | |
BP | -10.43% | 28.38 | $ |

Pfizer seeks US approval of Covid vaccine for children under 5
Pfizer and BioNTech said Tuesday they are seeking emergency authorization from US health regulators for use of their Covid vaccine for children aged over six months and under five years.
If the Food and Drug Administration (FDA) authorizes the two-shot regimen, it will become the first Covid vaccine available to this age group in the United States.
The companies said Tuesday that they started submitting their formal application "following a request" from the FDA, which seemingly wants to get the process moving quickly.
In a tweet soon after the announcement, the FDA said it will hold a meeting in two weeks, on February 15, to consider the request.
"Having a safe and effective vaccine available for children in this age group is a priority for the agency," said interim FDA head Janet Woodcock, who added that the FDA asked for the application "in light of the recent Omicron surge."
The companies are seeking authorization for only two doses of their vaccine, but believe a third will be needed "to achieve high levels of protection against current and potential future variants," Pfizer CEO Albert Bourla said in a statement.
"If two doses are authorized, parents will have the opportunity to begin a Covid-19 vaccination series for their children while awaiting potential authorization of a third dose," he added.
To limit side effects for this young age group, Pfizer chose to significantly decrease the dosage of its vaccine, opting for only three micrograms per jab versus 30 for those over 12 years old, and 10 for ages five to 11.
The company's researchers concluded last fall that low doses of the vaccine provided protection in children up to two years old but not in those aged two to five, and announced in December they would add a third dose to their trials.
Data on the three-dose regimen is "expected in the coming months and will be submitted to the FDA to support a potential expansion" of this initial request, Pfizer and BioNTech said in the statement.
If the FDA authorizes the emergency use of the vaccine, an advisory committee for the Centers for Disease Control and Prevention (CDC) will then meet to decide to recommend its use or not.
- Slower uptake among minors -
There are about 23 million children under the age of five in the United States, and two years after the pandemic began, many parents are waiting impatiently to vaccinate their young children against the coronavirus.
The Pfizer-BioNTech vaccine was approved three months ago for emergency use in children from five to 11, but uptake has been relatively slow.
In that age group, only 30 percent have received at least one dose and around 22 percent are fully vaccinated, according to the Centers for Disease Control and Prevention (CDC).
Young children are less susceptible to falling seriously ill with Covid-19, but some nonetheless end up hospitalized by the virus.
New pediatric Covid hospitalizations hit a record high in the United States in December as the Omicron strain spread rapidly.
Some cases of the life-threatening illness MIS-C (multi-system inflammatory syndrome in children), have also been reported in young children with Covid.
CDC data shows that about 400 children aged four and under have died from Covid-19 in the United States since the pandemic began.
O.Bulka--BTB